Latest News and Press Releases

Dublin, Feb. 14, 2025 (GLOBE NEWSWIRE) -- The "Hydroxychloroquine Drugs Market - Forecasts from 2025 to 2030" report has been added to ResearchAndMarkets.com's offering. In a comprehensive analysis...

The politicized response to Covid included a war on the use of ivermectin. Studies have conflicting results. The issue is at a stalemate.

A heavily politicized process suppressed the use of safe, affordable, repurposed drugs such as hydroxychoroquine for early treatment of COVID.

Evidence for benefit of hydroxychloroquine and other "off-label" drugs for COVID is hidden in plain sight, says infectious disease specialist.

Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "US Alopecia Areata - Market Insight, Epidemiology And Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. The latest...

Regulatory agencies and individuals, that have pervasive conflicts of interest, need to be held accountable for the disastrous COVID-19 response.

Dublin, Feb. 17, 2023 (GLOBE NEWSWIRE) -- The "Global Antimalarial Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028: Segmented By Drug Type, By Drug Class, By...

WASHINGTON, Feb. 16, 2022 (GLOBE NEWSWIRE) -- The Global Hydroxychloroquine Market size is expected to reach over USD 2,598.6 Million by 2028, exhibiting a Compound Annual Growth Rate (CAGR) of 5.7%...

Dublin, Jan. 28, 2022 (GLOBE NEWSWIRE) -- The "Rheumatoid Arthritis Drugs Market" report has been added to ResearchAndMarkets.com's offering. This report provides a detailed analysis of rheumatoid...

TUCSON, Ariz., Jan. 17, 2022 (GLOBE NEWSWIRE) -- The Association of American Physicians and Surgeons (AAPS) condemns the continued hoarding by the federal government of hydroxychloroquine, which it...